Results 241 to 250 of about 2,599,480 (386)

Body Biofluids for Minimally‐Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential

Advanced Healthcare Materials, EarlyView.
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao, Chandan Kumar Mandal, Fernando Patolsky   +2 more
wiley   +1 more source

The impact of CGRP monoclonal antibodies on cytokine expression in chronic migraine: a cohort study. [PDF]

J Neurol
Ray JC, McDonald S, Todaro M, Baker J, Yeh WZ, Hutton EJ, Matharu M, Butzkueven H.   +7 more
europepmc   +1 more source

Biomimetic Scaffolds with Dual Gradients of Biological Effectors for Tendon‐to‐Bone Repair

Advanced Healthcare Materials, EarlyView.
The authors have developed a biomimetic scaffold with dual gradients through a diffusion‐driven method. The scaffold features funnel‐shaped microchannels for cell infiltration, while the dual gradients synergetically induce the graded differentiation of mesenchymal stem cells into osteoblasts, chondrocytes, and tenocytes, allowing for a seamless ...
Min Hao, Yidan Chen, Stavros Thomopoulos, Younan Xia   +3 more
wiley   +1 more source

Prediction of aggregation in monoclonal antibodies from molecular surface curvature. [PDF]

Sci Rep
Knez B, Erzin L, Kos Ž, Kuzman D, Ravnik M.   +4 more
europepmc   +1 more source

Monoclonal antibodies in acute lymphoblastic leukemia.

Blood, 2015
E. Jabbour, S. O'brien, F. Ravandi, H. Kantarjian   +3 more
semanticscholar   +1 more source

Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk

Advanced Healthcare Materials, EarlyView.
Centralizes the microbiome within 3D tumor‐microbiome model platforms, including spheroids, organoids, 3D‐bioprinted constructs, and microfluidic chips, each enabling structured host‐tumor‐microbe studies. These systems support bacterial colonization, facilitating investigation of microbial impacts on tumor growth, immunity, and therapy. The microbiome
Marina Green Buzhor, Giuseppe Longobardi, Or Kandli, Anne Krinsky, Opal Avramoff, Anshika Katyal, Koren Salomon, Adan Miari, Dana Venkert, Tania T. Barnatan, América García Alvarado, Shahar Greenberg, Ronit Satchi‐Fainaro   +12 more
wiley   +1 more source

Do Anti-PCSK9 Monoclonal Antibodies Have Pleiotropic Effects? [PDF]

JACC Basic Transl Sci
Ferri N.
europepmc   +1 more source

Production of monoclonal antibodies to hepatitis B surface and core antigens, and use in the detection of viral antigens in liver biopsies [PDF]

, 1983
Richard S. Tedder, P. Guarascio, Jing Yao, R. Bridget Lord, A L Eddleston   +4 more
openalex   +1 more source

Asymmetry of acetylcholinesterase and acetylcholine receptor in intact secretory vesicles from adrenal medulla [PDF]

, 1981
Casey, Chubb, Chubb, Gratzl, Gratzl, Mizobe, Rotundo, Rotundo, Somogyi, Wilson   +9 more
core   +1 more source

Multivalent Protein Nanorings for Broad and Potent SARS‐CoV‐2 Neutralization

Advanced Healthcare Materials, EarlyView.
A protein‐only, modular multivalent nanoscaffold displaying 20 anchor points, decorated with two different binders (10 of each), targeting the SARS‐CoV‐2 receptor‐binding domain is presented. The construct self‐assembles into stable, biocompatible, homogeneous nanoparticles, exhibit synergistic binding with fM IC50 values. It also detects spike at 9 ng 
Molood Behbahanipour, Carla Goldin, Cecilia Arahi Prato, Ana Luz Paletta, Oriol Bárcenas, Susanna Navarro, Jordi Pujols, Daniel H. Murgida, María Virginia Tribulatti, Sebastián Esperante, Damian Alvarez‐Paggi, Salvador Ventura   +11 more
wiley   +1 more source